Clinical Trial Update: Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors) [NA]

View source ↗

Summary

The clinical trial GT316 using autologous tumor-infiltrating lymphocytes for advanced solid tumors, including gynecologic tumors, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• GT316

Snippet

Sponsor: Grit Biotechnology | Conditions: Solid Tumor, Gynecological Tumors | NA | Status: RECRUITING